Hormonal Imbalances and Metabolic Syndrome

Metabolic syndrome is characterized by central obesity, dyslipidemia, hypertension, and hyperglycemia, with hormonal dysregulation as a key driver. Insulin, cortisol, thyroid hormones, and sex hormones significantly influence metabolic homeostasis. Imbalances in these endocrine systems exacerbate obesity and increase cardiometabolic risk. Clinical management requires integrated approaches combining pharmacological therapy, lifestyle modification, and targeted hormone interventions. Advances in endocrinology and metabolic research are refining strategies to identify at-risk individuals early and to optimize therapeutic outcomes through precision approaches.

    Related Conference of Hormonal Imbalances and Metabolic Syndrome

    October 20-21, 2025

    25th Global Summit on Obesity

    Dubai, UAE
    March 26-27, 2026

    28th Global Obesity Meeting

    London, UK
    June 15-16, 2026

    22nd Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Hormonal Imbalances and Metabolic Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in